Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-2_14-cv-02085/USCOURTS-caed-2_14-cv-02085-6/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 28:1338 Patent Infringement

---

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

1

UNITED STATES DISTRICT COURT

EASTERN DISTRICT OF CALIFORNIA

CESCA THERAPEUTICS INC., 

Plaintiff,

v.

SYNGEN INC., a California 

corporation; PHC MEDICAL, 

INC., a California

corporation; PHILIP COELHO, 

an individual; TERRENCE WOLF, 

an individual; PRINCE 

EMMANUEL, an individual; and 

DOES 1 through 10, inclusive;

Defendants.

No. 2:14-cv-02085-GEB-KJN

ORDER 

The joint stipulation filed March 23, 2015, (ECF No. 

34), reveals this case is not ready to be scheduled. Therefore, 

the Status (Pretrial Scheduling) Conference scheduled for hearing 

on April 20, 2015, is continued to June 22, 2015, at 9:00 a.m. A 

joint status report shall be filed no later than fourteen (14) 

days prior to the Status Conference. 

Further, in light of the stipulation the pending motion 

to compel arbitration, (ECF No. 31), is deemed withdrawn; 

therefore, the April 13, 2015 hearing on that motion is vacated.

IT IS SO ORDERED.

Dated: March 25, 2015

Case 2:14-cv-02085-TLN-KJN Document 35 Filed 03/25/15 Page 1 of 1